GENSIGHT BIOLOGICS SA (SIGHT.PA) Forecast, Price Target & Analyst Ratings

EPA:SIGHT • FR0013183985

Current stock price

0.082 EUR
+0 (+0.99%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for GENSIGHT BIOLOGICS SA (SIGHT.PA).

Forecast Snapshot

Consensus Price Target

Price Target
€0.31
+ 279.39% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Jul 8, 2026
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
80.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
€0.31
Upside
+ 279.39%
From current price of €0.08 to mean target of €0.31, Based on 11 analyst forecasts
Low
€0.21
Median
€0.31
High
€0.42

Price Target Revisions

1 Month
-29.07%
3 Months
-29.07%

Price Target Summary

11 Wall Street analysts provided a forecast for the next 12 months for SIGHT.PA. The average price target is 0.31 EUR. This implies a price increase of 279.39% is expected in the next year compared to the current price of 0.082.
The average price target has been revised downward by 29.07% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

SIGHT Current Analyst RatingSIGHT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

SIGHT Historical Analyst RatingsSIGHT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
80.00%
SIGHT.PA was analyzed by 11 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about SIGHT.PA.
In the previous month the buy percentage consensus was at a similar level.
SIGHT.PA was analyzed by 11 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
Jul 8, 2026

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
SIGHT.PA revenue by date.SIGHT.PA revenue by date.
1.267M
-50.93%		1.5M
18.39%		1K
-99.93%		2.575M
257,400.00%		21.63M
740.00%		78.28M
261.90%		N/AN/A
EBITDA
YoY % growth
SIGHT.PA ebitda by date.SIGHT.PA ebitda by date.
-27.517M
-2.78%		-14.754M
46.38%		-10.589M
28.23%		-24.205M
-128.59%		-18.025M
25.53%		8.24M
145.71%		N/AN/A
EBIT
YoY % growth
SIGHT.PA ebit by date.SIGHT.PA ebit by date.
-29.696M
-6.69%		-15.813M
46.75%		-11.054M
30.10%		-25.75M
-132.95%		-19.57M
24.00%		143.98M
835.72%		210.23M
46.01%		275.99M
31.28%
Operating Margin
SIGHT.PA operating margin by date.SIGHT.PA operating margin by date.
-2,343.80%-1,054.20%-1,105,400.00%-1,000.00%-90.48%183.93%N/AN/A
EPS
YoY % growth
SIGHT.PA eps by date.SIGHT.PA eps by date.
N/A
28.07%		N/A
11.28%		N/A
24.74%		-0.61
-61.64%		-0.54
11.02%		-0.20
63.81%		N/AN/A

All data in EUR

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in EUR

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

SIGHT.PA Yearly Revenue VS EstimatesSIGHT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M
SIGHT.PA Yearly EPS VS EstimatesSIGHT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -0.2 -0.4 -0.6 -0.8 -1

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
13.95%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
193.70%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
33.06%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

GENSIGHT BIOLOGICS SA / SIGHT.PA Forecast FAQ

Can you provide the average price target for GENSIGHT BIOLOGICS SA stock?

11 analysts have analysed SIGHT.PA and the average price target is 0.31 EUR. This implies a price increase of 279.39% is expected in the next year compared to the current price of 0.082.

When does GENSIGHT BIOLOGICS SA (SIGHT.PA) report earnings?

GENSIGHT BIOLOGICS SA (SIGHT.PA) will report earnings on 2026-07-08.

What is the consensus rating for SIGHT stock?

The consensus rating for GENSIGHT BIOLOGICS SA (SIGHT.PA) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.